BL-B01D1-207: A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Oct 10, 2026 - P2 | N=76 | Active, not recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting | N=40 ➔ 76 | Trial completion date: Aug 2026 ➔ Jun 2027 | Trial primary completion date: Aug 2026 ➔ Jun 2027
Enrollment change • Enrollment closed • Trial completion date • Trial primary completion date • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • EGFR
|